US2003056788A1PendingUtilityA1

Partial liquid breathing of fluorocarbons

Priority: May 3, 1991Filed: Aug 14, 2001Published: Mar 27, 2003
Est. expiryMay 3, 2011(expired)· nominal 20-yr term from priority
A61P 31/04A61P 43/00A61K 31/035A61K 31/685A61M 2202/0476A61K 31/025A61K 31/13A61P 11/00A61P 11/10A61K 45/06Y10S128/913A61K 31/135A61K 31/02A61K 31/08
53
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention includes a method for treating a patient in need of facilitated oxygen delivery through the lungs, additional lung surfactant, removal of material from inside the lung, or inflation of collapsed portions of the lung, comprising the step of introducing into the lung of the patient an effective therapeutic amount of a fluorocarbon liquid, the amount not exceeding the functional residual capacity of the lung of the patient upon exhalation taking into account any positive and expiratory pressure applied to the patient's lung. The method may also comprise the additional step of providing an oxygen-containing breathing gas to the patient while the fluorocarbon liquid is in the lung.

Claims

exact text as granted — not AI-modified
What is claimed is:  
     
         1 . A method for treating a patient in need of facilitated oxygen delivery through the lungs, additional lung surfactant, removal of material from inside the lung, or inflation of collapsed portions of the lung, comprising the step of introducing into the lung of the patient an effective therapeutic amount of perfluorooctylbromide, said amount being more than 0.1% and less than 50% of the functional residual capacity of the lung of the patient at the end of exhalation taking into account any positive and expiratory pressure applied to the patient's lung.

Join the waitlist — get patent alerts

Track US2003056788A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.